279 results on '"XU Peng-peng"'
Search Results
2. Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma
3. Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma
4. Study of electromagnetic interference suppression method for switched reluctance motor
5. Development of Blocking Function of Leakage Communication and Shaft Hoist Signal
6. Electrical Parameter Acquisition System Based on S7-300/200 PLC and Modbus Protocol
7. Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma
8. Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma
9. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma
10. The prognostic value of CT-derived fractional flow reserve in coronary artery bypass graft: a retrospective multicenter study
11. Artificial intelligence in coronary computed tomography angiography
12. Genomic and transcriptomic profiling of peripheral T cell lymphoma reveals distinct molecular and microenvironment subtypes
13. GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis
14. Tucidinostat plus R-CHOP in previously untreated diffuse large B-cell lymphoma with double expression of MYC and BCL2: An interim analysis from the phase III DEB study.
15. Coronary artery calcification and risk of mortality and adverse outcomes in patients with COVID-19: a Chinese multicenter retrospective cohort study
16. Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells
17. Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma
18. Optimal Measurement Sites of Coronary-Computed Tomography Angiography-derived Fractional Flow Reserve: The Insight From China CT-FFR Study
19. CD47 overexpression is related to tumour‐associated macrophage infiltration and diffuse large B‐cell lymphoma progression
20. Targeted Agents Plus CHOP Compared with CHOP as the First-Line Treatment for Newly Diagnosed Patients with Peripheral T-Cell Lymphoma (GUIDANCE-03): An Open-Label, Multicentre Phase 2 Clinical Trial
21. Nonlinear intensity measurement for multi-source images based on structural similarity
22. Serial coronary CT angiography–derived fractional flow reserve and plaque progression can predict long-term outcomes of coronary artery disease
23. The effect of coronary calcification on diagnostic performance of machine learning–based CT-FFR: a Chinese multicenter study
24. Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor.
25. Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
26. Paclitaxel may inhibit migration and invasion of gastric cancer cells via nod‐like receptor family pyrin domain‐containing 3/caspase‐1/Gasdermin E mediated pyroptosis pathway
27. Correction to: Serial coronary CT angiography–derived fractional flow reserve and plaque progression can predict long-term outcomes of coronary artery disease
28. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis
29. CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis
30. Coronary computed tomography angiography derived flow fractional reserve: the state of the art
31. The influence of image quality on diagnostic performance of a machine learning–based fractional flow reserve derived from coronary CT angiography
32. Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial
33. The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review
34. A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes
35. Paclitaxel may inhibit migration and invasion of gastric cancer cells via nod‐like receptor family pyrin domain‐containing 3/caspase‐1/Gasdermin E mediated pyroptosis pathway.
36. Prognostic Value of CT-FFR–Based Functional Duke Jeopardy Score in Patients With Suspected CAD
37. Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial
38. P1164: PEGARSPARGASE AND SINTILIMAB FOR NEWLY DIAGNOSED, ADVANCED STAGE NATURAL KILLER T-CELL LYMPHOMA, NASAL TYPE: AN OPEN-LABEL, SINGLE-ARM, PHASE 2 STUDY.
39. P1120: NOVEL TARGETED AGENTS IN COMBINATION WITH R-ICE (R-ICE-X) BASED ON GENOTYPING IN RELAPSED/REFRACTORY DLBCL.
40. Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma
41. Construction and validation of a differentiation scoring system for Spotted fever and Severe fever with thrombocytopenia syndrome
42. CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial
43. Figure S1 from Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma
44. Table S2 from Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma
45. Data from Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma
46. A Coronary CT Angiography Radiomics Model to Identify Vulnerable Plaque and Predict Cardiovascular Events
47. Artificial Intelligence Based Fully-Automated One-Click On-Site CT-Derived Fractional Flow Reserve: A Stepwise Development and Validation from Multicohort China CT-FFR Studies
48. Positron emission tomography‐adapted therapy in low‐risk diffuse large B‐cell lymphoma: results of a randomized, phase III, non‐inferiority trial.
49. The prognostic value of CT-derived fractional flow reserve in coronary artery bypass graft: a retrospective multicenter study
50. Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.